Polymers - a synthetic or natural choice?

被引：6

作者：

Bacon, A ^{[1
]}

机构：

[1] Lipoxen Technol, Sch Pharm, London WC1 1AX, England

来源：

DRUG DISCOVERY TODAY | 2002年 / 7卷 / 24期

关键词：

D O I：

10.1016/S1359-6446(02)02531-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1202 / 1203

页数：2

共 5 条

[1]

BRISTOW AF, 1998, P EQA 1998 PART M, P66

[2] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].

Fried, MW ;

Shiffman, ML ;

Reddy, KR ;

Smith, C ;

Marinos, G ;

Goncales, FL ;

Haussinger, D ;

Diago, M ;

Carosi, G ;

Dhumeaux, D ;

Craxi, A ;

Lin, A ;

Hoffman, J ;

Yu, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982

[3] Polysialic acids: potential in improving the stability and pharmacokinetics of proteins and other therapeutics [J].

Gregoriadis, G ;

Fernandes, A ;

Mital, M ;

McCormack, B .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (13-14) :1964-1969

[4] Therapeutic synthetic polymers: a game of Russian roulette? [J].

Hunter, AC ;

Moghimi, SM .

DRUG DISCOVERY TODAY, 2002, 7 (19) :998-1001

[5] The danger model: A renewed sense of self [J].

Matzinger, P .

SCIENCE, 2002, 296 (5566) :301-305

← 1 →